Myriad Genetics (MYGN) Assets Growth (1y) (2011 - 2026)
Myriad Genetics (MYGN) Assets Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 214.22 Bn | 210.16 Bn | 8.34 Bn |
| 2 | Danaher | 140.38 Bn | 136.03 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.15 Bn | 45.95 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.80 Bn | 37.99 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.51 Bn | 37.43 Bn | 1.44 Bn |
| 6 | Natera | 38.83 Bn | 37.73 Bn | 696.04 Mn |
| 7 | Illumina | 30.02 Bn | 28.85 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.64 Bn | 28.59 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.54 Bn | 1.03 Bn |
| 10 | Myriad Genetics | 294.22 Mn | 169.82 Mn | 137.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.04% |
| Dec 31, 2025 | -31.24% |
| Sep 30, 2025 | -32.66% |
| Jun 30, 2025 | -37.58% |
| Mar 31, 2025 | -9.40% |
| Dec 31, 2024 | -10.37% |
| Sep 30, 2024 | -5.90% |
| Jun 30, 2024 | -8.60% |
| Mar 31, 2024 | -5.03% |
| Dec 31, 2023 | -4.35% |
| Sep 30, 2023 | -5.19% |
| Jun 30, 2023 | -1.90% |
| Mar 31, 2023 | -6.86% |
| Dec 31, 2022 | -9.24% |
| Sep 30, 2022 | -9.27% |
| Jun 30, 2022 | -11.03% |
| Mar 31, 2022 | -6.10% |
| Dec 31, 2021 | -6.91% |
| Sep 30, 2021 | -7.52% |
| Jun 30, 2021 | -3.15% |